MediGene AG To Participate In Two International Conferences

Martinsried/Munich, 15 June, 2015. Medigene AG (MDG1, Frankfurt, Prime Standard) announces its participation in two further conferences:

• BIO International Convention - The Global Event for Biotechnology
Date: 15 - 18 June 2015
Location: Philadelphia, USA

• ODDO SEYDLER BANK Munich Biotech Days
Date: 1 - 2 July 2015
Location: Munich, Germany

Medigene AG is a publicly listed (Frankfurt: MDG1, prime standard) biotechnology company headquartered in Martinsried near Munich, Germany. Medigene concentrates on the development of personalized T cell immunotherapies with a focus on haematological malignancies. Medigene is the first German biotech company to have revenues from a marketed product, which is distributed by commercial partner companies. Medigene has advanced drug candidates which are licensed to partners and additional candidates in clinical development. The company is developing highly innovative treatment platforms concentrating on cancer and autoimmune diseases. For more information, please visit

Help employers find you! Check out all the jobs and post your resume.

Back to news